Skip to main content

Table 5 Bivariate and multivariate logistic regression analysis of factors associated with early, late and long-term readmissions

From: Factors associated with readmissions in women participating in screening programs and treated for breast cancer: a retrospective cohort study

 

Early readmission

Odds Ratio (95% CI)

Late readmission

Odds Ratio (95% CI)

Long-term readmission

Odds Ratio (95% CI)

Unadjusted

Adjusted1

Unadjusted

Adjusted1

Unadjusted

Adjusted1

Detection mode

 Screen-detected

Ref.

Ref.

Ref.

Ref.

Ref.

Ref.

 Interval cancer

1.14 (0.70–1.86)

0.73 (0.32–1.66)

0.86 (0.53–1.40)

0.60 (0.23–1.53)

1.54 (0.94–2.53)

0.65 (0.22–1.88)

Tumor-node-metastasis stage

 In situ

0.73 (0.30–1.78)

1.44 (0.14–15.15)

0.94 (0.42–2.07)

2.55 (0.24–27.53)

1.25 (0.45–3.46)

5.21 (0.31–88.88)

 Stage I

Ref.

Ref.

Ref.

Ref.

Ref.

Ref.

 Stage II

0.97 (0.57–1.65)

0.65 (0.26–1.61)

0.96 (0.57–1.61)

1.93 (0.68–5.46)

2.29 (1.25–4.22)

0.93 (0.30–2.92)

 Stage III/IV

0.61 (0.26–1.39)

0.27 (0.06–1.30)

0.93 (0.46–1.86)

2.71 (0.55–13.42)

3.31 (1.66–6.62)

1.64 (0.33–8.10)

Surgical treatment

 Conservative2 surgery without lymphadenectomy

1.65 (0.96–2.84)

2.91 (1.13–7.52)

1.09 (0.66–1.78)

1.26 (0.45–3.53)

0.45 (0.22–0.92)

0.46 (0.11–1.87)

 Conservative2 surgery with lymphadenectomy

Ref.

Ref.

Ref.

Ref.

Ref.

Ref.

 Radical3 surgery with or without lymphadenectomy

1.54 (0.82–2.89)

2.54 (0.84–7.71)

0.76 (0.40–1.45)

0.46 (0.12–1.76)

2.04 (1.17–3.55)

1.57 (0.46–5.30)

Surgical complications4

 No

Ref.

Ref.

Ref.

Ref.

Ref.

Ref.

 Yes

1.91 (1.09–3.34)

3.62 (1.27–10.29)

1.13 (0.62–2.05)

1.23 (0.36–4.16)

1.33 (0.71–2.49)

0.59 (0.18–1.97)

Medical complications5

 No

Ref.

Ref.

Ref.

Ref.

Ref.

Ref.

 Yes

2.55 (1.50–4.32)

2.69 (0.84–8.60)

3.28 (2.02–5.32)

8.72 (2.83–26.86)

3.76 (2.24–6.31)

4.79 (1.41–16.31)

  1. 1 Model adjusted by age, Charlson Index, detection mode, tumor-node metastasis stage, focality, tumor grade, tumor phenotype, surgical and adjuvant treatment, general complications, surgical and medical complications, and screening program
  2. 2 Included: quadrantectomy, tumorectomy, and segmentectomy
  3. 3 Included: simple mastectomy, radical mastectomy, and modified radical mastectomy
  4. 4 Included: lymphedema, adhesions, skin infection, and soft tissue necrosis
  5. 5 Included: treatment toxicity, endometrial alterations, hypothyroidism, mycosis, vascular insufficiency, asthenia, palpitations, mastitis, and depression